News summary
[Hengrui Medicinesweetbonanzabuyfeature: Subsidiary obtains approval notice for drug clinical trials] Securities Times e Company News, Hengrui Pharmaceutical (600276) announced on the evening of May 8 that the company's subsidiary Fujian Shengdi Pharmaceutical Co., Ltd. recently received approval from the State Food and Drug Administration for injection."Clinical Drug of HRS5580sweetbonanzabuyfeature...
Newsletter text
[Hengrui Pharmaceutical: Subsidiary obtains drug clinical trial approval notice] Securities Times e Company News, Hengrui Pharmaceutical (600276) announced on the evening of May 8 that the company's subsidiary Fujian Shengdi Pharmaceutical Co., Ltd. recently received approval from the State Food and Drug Administration for the approval of HRS5580 for injection; subsidiary Chengdu Shengdi Pharmaceutical Co., Ltd. recently received approval from the State Food and Drug Administration for the issuance of the "Drug Clinical Trial Approval Notice" on HRS-5965 capsule.
